Stock abbreviation: Zhejiang Hisun Pharmaceutical Co.Ltd(600267) Stock Code: Zhejiang Hisun Pharmaceutical Co.Ltd(600267) Announcement No.: Lin 202263 bond abbreviation: Haizheng fixed transfer bond Code: 110813
Zhejiang Hisun Pharmaceutical Co.Ltd(600267)
Announcement on adjusting the conversion price of convertible corporate bonds
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content tips:
Conversion price before adjustment: 12.99 yuan / share
Adjusted conversion price: 12.85 yuan / share
Effective date of share conversion price adjustment: May 27, 2022
“Haizheng fixed transfer” will stop the share transfer from May 20, 2022 to May 26, 2022 (equity distribution and equity registration date), and resume the share transfer from May 27, 2022.
Zhejiang Hisun Pharmaceutical Co.Ltd(600267) (hereinafter referred to as “the company”) has completed the issue of shares, convertible corporate bonds, payment of cash to purchase assets and raising supporting funds and related party transactions in March 2021. The number of non-public issuance of convertible corporate bonds is 18152415, which has been registered on March 18, 2021, with a face value of 100 yuan each and a total amount of 1815241500 yuan, The term is 6 years from the date of issuance. The bond is referred to as “Haizheng fixed transfer” for short, and the bond code is “110813”.
The starting and ending time of “Haizheng fixed transfer” is from March 18, 2021 to March 17, 2027, and the starting and ending time of share conversion is from September 22, 2021 to March 17, 2027 (the starting date of share conversion period was September 18, 2021. Since September 18 is a non Trading day, the starting date of share conversion period will be postponed to the first trading day thereafter).
1、 Adjustment basis of conversion price
The company’s profit distribution plan for 2021 is: Based on the company’s current total share capital of 1198657562 shares, deducting 10621459 shares repurchased so far, the number of shares participating in this equity distribution is 1188036103 shares, cash of 1.4 yuan (tax included) is distributed to all shareholders for every 10 shares, and a total cash dividend of 16632505442 yuan (tax included) is distributed, and the remaining undistributed profits are carried forward to the next year. In 2021, no shares will be given and no capital reserve will be converted into share capital. For details, please refer to China Securities News, Shanghai Securities News, securities times and the website of Shanghai Stock Exchange (www.sse. Com. CN.) Announcement of Zhejiang Hisun Pharmaceutical Co.Ltd(600267) on adjusting the total cash dividend of profit distribution in 2021 (Announcement No.: Lin 202261).
According to the relevant provisions of the report on Zhejiang Hisun Pharmaceutical Co.Ltd(600267) issuing shares, convertible corporate bonds, paying cash to purchase assets and raising matching funds and related party transactions (Revised Version), during the period from the pricing base date to the maturity date of convertible corporate bonds, when the company distributes stock dividends, converts to share capital, allots shares (when the allotment price is lower than the current conversion price), and distributes cash dividends, The company will adjust the conversion price according to the relevant formula.
Therefore, the conversion price of “Haizheng fixed transfer” will be adjusted. This adjustment is in line with the provisions of the report on Zhejiang Hisun Pharmaceutical Co.Ltd(600267) issuing shares, convertible corporate bonds, paying cash to purchase assets and raising supporting funds and related party transactions (Revised Version).
2、 Conversion price adjustment formula and adjustment result
(I) adjustment formula of conversion price
According to the relevant provisions of the report on Zhejiang Hisun Pharmaceutical Co.Ltd(600267) issuing shares, convertible corporate bonds, paying cash to purchase assets and raising matching funds and related party transactions (Revised Version), when the company distributes stock dividends, converted capital stock, allotment of shares (when the allotment price is lower than the current conversion price) and cash dividends from the pricing base date to the maturity date of convertible corporate bonds, The conversion price will be adjusted according to the following formula, and the calculation result will be rounded up and accurate to minutes. The adjustment formula of share conversion price is as follows: share dividend or capital reserve converted into share capital: P1 = P0 / (1 + n);
Allotment: P1 = (P0 + a) × k）/（1+k）；
The above two items shall be carried out simultaneously: P1 = (P0 + a) × k）/（1+n+k）；
Cash dividend: P1 = p0-d;
The above three items shall be carried out simultaneously: P1 = (p0-d + a) × k）/（1+n+k）。
Where: P0 is the effective share conversion price before adjustment, n is the share delivery rate or share capital conversion rate, K is the share allotment rate, a is the share allotment price, D is the cash dividend distributed per share, and P1 is the effective share conversion price after adjustment. When the above shares and / or shareholders’ equity changes, the company will adjust the conversion price in turn, and specify the date of adjustment, adjustment method and suspension period of conversion price in the announcement (if necessary). When the adjustment date of share conversion price is on or after the application date of HPPC share conversion and before the registration date of conversion shares, the application for share conversion of HPPC shall be executed according to the adjusted share conversion price of the company.
(II) adjustment results of share conversion price
According to the above terms, the conversion price of “Haizheng fixed transfer” before adjustment is 12.99 yuan / share, and the adjusted conversion price is 12.85 yuan / share. The adjusted conversion price will take effect from May 27, 2022 (ex right and ex interest date). “Haizheng fixed transfer” will stop the share transfer from May 20, 2022 to May 26, 2022 (equity distribution and equity registration date), and resume the share transfer from May 27, 2022 (ex right and ex interest date).
It is hereby announced.
Zhejiang Hisun Pharmaceutical Co.Ltd(600267) board of directors may 21, 2002
